Caricamento...
Insulin degludec/liraglutide (IDegLira) for the treatment of type 2 diabetes
The progressive nature of type 2 diabetes necessitates that treatment is intensified as the disease advances. Several studies have shown that basal insulin and glucagon-like peptide-1 receptor agonists (GLP-1RAs) can be used in combination to successfully improve glycemic control and this combinatio...
Salvato in:
| Pubblicato in: | Expert Rev Endocrinol Metab |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4894076/ https://ncbi.nlm.nih.gov/pubmed/27335581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/17446651.2016.1113129 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|